Skip to main content
Clinical Trials/NCT01359527
NCT01359527
Completed
Not Applicable

A Dual Energy X-Ray Absorptiometry Comparison Of Periprosthetic Bone Loss Between Patients Undergoing Hip Resurfacing Surgery And Total Hip Arthroplasty

Spokane Joint Replacement Center1 site in 1 country31 target enrollmentDecember 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis, Hip
Sponsor
Spokane Joint Replacement Center
Enrollment
31
Locations
1
Primary Endpoint
Bone Mineral Density
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement.

Detailed Description

This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement. The goal is to evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
November 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Spokane Joint Replacement Center
Responsible Party
Principal Investigator
Principal Investigator

David F. Scott, MD

PI

Spokane Joint Replacement Center

Eligibility Criteria

Inclusion Criteria

  • Age of at least 20 years
  • Osteoarthritis
  • Elective Total Hip Arthroplasty / Resurfacing
  • Signed Informed Consent

Exclusion Criteria

  • Osteoporosis
  • Revisions
  • Femoral dysplasia
  • Trochanteric osteotomy
  • Inflammatory arthritis
  • Breast-feeding, pregnancy, or women of child-bearing potential without documentation of a negative pregnancy test and not utilizing contraception
  • Patients with a history of having taken or currently taking PTH, fluoride therapy or strontium ranelate or patients taking other chronic medications that in the Investigator's opinion are known to affect bone mineral density in a substantial way
  • Patients with severe medical condition(s) that in the view of the Investigator prohibits participation in the study
  • Use of any other investigational agent in the last 30 days

Outcomes

Primary Outcomes

Bone Mineral Density

Time Frame: Baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative

To evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.

Secondary Outcomes

  • Harris Hip Score(Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative)

Study Sites (1)

Loading locations...

Similar Trials